Efficacy of a combination of imatinib and low dose ara-C in elderly or high-risk patients with AML and MDS, as measured by the rate of early mortality or progression. April 2007 [clinicaltrials_resource:29e585631c4d5464295fc46d3dbfdcab]
600 mg (capsules) by mouth once daily
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Efficacy of a combination of imatinib and low dose ara-C in elderly or high-risk patients with AML and MDS, as measured by the rate of early mortality or progression. April 2007 [clinicaltrials_resource:29e585631c4d5464295fc46d3dbfdcab]
600 mg (capsules) by mouth once daily
Bio2RDF identifier
29e585631c4d5464295fc46d3dbfdcab
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:29e585631c4d5464295fc46d3dbfdcab
measure [clinicaltrials_vocabulary:measure]
Efficacy of a combination of i ...... arly mortality or progression.
time frame [clinicaltrials_vocabulary:time-frame]
April 2007
description
600 mg (capsules) by mouth once daily
identifier
clinicaltrials_resource:29e585631c4d5464295fc46d3dbfdcab
title
Efficacy of a combination of i ...... ity or progression. April 2007
@en
type
label
Efficacy of a combination of i ...... 585631c4d5464295fc46d3dbfdcab]
@en